Skip to main content
Top
Published in: European Journal of Epidemiology 10/2019

01-10-2019 | META-ANALYSIS

Green tea consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan

Authors: Sarah Krull Abe, Eiko Saito, Norie Sawada, Shoichiro Tsugane, Hidemi Ito, Yingsong Lin, Akiko Tamakoshi, Junya Sado, Yuri Kitamura, Yumi Sugawara, Ichiro Tsuji, Chisato Nagata, Atsuko Sadakane, Taichi Shimazu, Tetsuya Mizoue, Keitaro Matsuo, Mariko Naito, Keitaro Tanaka, Manami Inoue, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan

Published in: European Journal of Epidemiology | Issue 10/2019

Login to get access

Abstract

The aim of our study was to assess the association between green tea consumption and all-cause and cause-specific mortality in a pooled analysis of eight Japanese population-based cohort studies. Pooled hazard ratios (HR) and 95% confidence intervals (CI), derived from random effects models, were used to evaluate the associations between green tea consumption, based on self-report at baseline, and risk of all-cause and cause-specific mortality. During a mean follow-up of 17.3 years, among 313,381 persons, 52,943 deaths occurred. Compared with individuals who consumed < 1 cup/day, those in the highest consumption category (≥ 5 cups/day) had a decreased risk of all-cause mortality [the multivariate-adjusted HR was 0.90 (95% CI 0.87–0.94) for men and 0.82 (0.74–0.90) for women]. A similar inverse association was observed for heart disease mortality [HR 0.82 (0.75–0.90) for men, and 0.75 (0.68–0.84) for women], and cerebrovascular disease mortality [HR 0.76 (0.68–0.85) for men, and 0.78 (0.68–0.89) for women]. Among women, green tea consumption was associated with decreased risk of total cancer mortality: 0.89 (0.83–0.96) for the 1–2 cups/day category and 0.91 (0.85–0.98) for the 3–4 cups/day category. Results for respiratory disease mortality were [HR 0.75 (0.61–0.94)] among 3–4 cup daily consumers and [HR 0.66 (0.55–0.79)] for ≥ 5 cups/day. Higher consumption of green tea is associated with lower risk for all-cause mortality in Japanese, especially for heart and cerebrovascular disease. Moderate consumption decreased the risk of total cancer and respiratory disease mortality in women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21(3):334–50.CrossRefPubMed Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21(3):334–50.CrossRefPubMed
3.
go back to reference Iso H, Date C, Wakai K, Fukui M, Tamakoshi A, Group JS. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med. 2006;144(8):554–62.CrossRefPubMed Iso H, Date C, Wakai K, Fukui M, Tamakoshi A, Group JS. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med. 2006;144(8):554–62.CrossRefPubMed
11.
go back to reference Eisenstein M. Tea’s value as a cancer therapy is steeped in uncertainty. Nature. 2019;566(7742):S6.CrossRefPubMed Eisenstein M. Tea’s value as a cancer therapy is steeped in uncertainty. Nature. 2019;566(7742):S6.CrossRefPubMed
12.
go back to reference Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF Jr. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst. 1994;86(11):855–8.CrossRefPubMed Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF Jr. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst. 1994;86(11):855–8.CrossRefPubMed
13.
go back to reference Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology. 2001;12(6):695–700.CrossRefPubMed Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology. 2001;12(6):695–700.CrossRefPubMed
14.
go back to reference Ishikawa A, Kuriyama S, Tsubono Y, et al. Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men. J Epidemiol Jpn Epidemiol Assoc. 2006;16(5):185–92.CrossRef Ishikawa A, Kuriyama S, Tsubono Y, et al. Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men. J Epidemiol Jpn Epidemiol Assoc. 2006;16(5):185–92.CrossRef
16.
go back to reference Wang M, Guo C, Li M. A case-control study on the dietary risk factors of upper digestive tract cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 1999;20(2):95–7.PubMed Wang M, Guo C, Li M. A case-control study on the dietary risk factors of upper digestive tract cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 1999;20(2):95–7.PubMed
17.
go back to reference Inoue M, Tajima K, Hirose K, et al. Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control. 1998;9(2):209–16.CrossRefPubMed Inoue M, Tajima K, Hirose K, et al. Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control. 1998;9(2):209–16.CrossRefPubMed
18.
go back to reference Mu LN, Zhou XF, Ding BG, et al. A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24(3):192–5.PubMed Mu LN, Zhou XF, Ding BG, et al. A case-control study on drinking green tea and decreasing risk of cancers in the alimentary canal among cigarette smokers and alcohol drinkers. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24(3):192–5.PubMed
22.
go back to reference Tamakoshi A, Yoshimura T, Inaba Y, et al. Profile of the JACC study. J Epidemiol Jpn Epidemiol Assoc. 2005;15(Suppl 1):S4–8.CrossRef Tamakoshi A, Yoshimura T, Inaba Y, et al. Profile of the JACC study. J Epidemiol Jpn Epidemiol Assoc. 2005;15(Suppl 1):S4–8.CrossRef
23.
go back to reference Tsuji I, Nishino Y, Tsubono Y, et al. Follow-up and mortality profiles in the Miyagi Cohort Study. J Epidemiol Jpn Epidemiol Assoc. 2004;14(Suppl 1):S2–6.CrossRef Tsuji I, Nishino Y, Tsubono Y, et al. Follow-up and mortality profiles in the Miyagi Cohort Study. J Epidemiol Jpn Epidemiol Assoc. 2004;14(Suppl 1):S2–6.CrossRef
31.
go back to reference World Health Organization. International statistical classification of diseases and related health problems. 10th Revision. Geneva: WHO; 1992. World Health Organization. International statistical classification of diseases and related health problems. 10th Revision. Geneva: WHO; 1992.
32.
43.
go back to reference Wang H, Provan G, Helliwell K. The functional benefits of flavonoids: the case of tea. In: Johnson I, Williamson G, editors. Phytochemical funtional foods. Cambridge: Woodhead Publishing; 2003. Wang H, Provan G, Helliwell K. The functional benefits of flavonoids: the case of tea. In: Johnson I, Williamson G, editors. Phytochemical funtional foods. Cambridge: Woodhead Publishing; 2003.
44.
go back to reference Schneider C, Segre T. Green tea: potential health benefits. Am Fam Physician. 2009;79(7):591–4.PubMed Schneider C, Segre T. Green tea: potential health benefits. Am Fam Physician. 2009;79(7):591–4.PubMed
48.
go back to reference Zucchi R, Ronca-Testoni S. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol Rev. 1997;49(1):1–51.PubMed Zucchi R, Ronca-Testoni S. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol Rev. 1997;49(1):1–51.PubMed
Metadata
Title
Green tea consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan
Authors
Sarah Krull Abe
Eiko Saito
Norie Sawada
Shoichiro Tsugane
Hidemi Ito
Yingsong Lin
Akiko Tamakoshi
Junya Sado
Yuri Kitamura
Yumi Sugawara
Ichiro Tsuji
Chisato Nagata
Atsuko Sadakane
Taichi Shimazu
Tetsuya Mizoue
Keitaro Matsuo
Mariko Naito
Keitaro Tanaka
Manami Inoue
Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan
Publication date
01-10-2019
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 10/2019
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-019-00545-y

Other articles of this Issue 10/2019

European Journal of Epidemiology 10/2019 Go to the issue